Risk factors for severe disease in patients admitted with COVID-19 to a hospital in London, England: a retrospective cohort study. (13th October 2020)

• Record Type: Journal Article
• Authors: Goodall, J. W.; Reed, T. A. N.; Ardissino, M.; Bassett, P.; Whittington, A. M.; Cohen, D. L.; Vaid, N.
• Is Part Of: Epidemiology and infection. Volume 148(2020)
• Publication Date: 2020-10-13
• Subjects: COVID-19, -- hospitalisation, -- severe disease; Communicable diseases -- Periodicals; Epidemiology -- Periodicals; 614.4
• DOI: 10.1017/S0950268820002472
• Languages: English
• ISSNs: 0950-2688

Abstract

Abstract: COVID-19 has caused a major global pandemic and necessitated unprecedented public health restrictions in almost every country. Understanding risk factors for severe disease in hospitalised patients is critical as the pandemic progresses. This observational cohort study aimed to characterise the independent associations between the clinical outcomes of hospitalised patients and their demographics, comorbidities, blood tests and bedside observations. All patients admitted to Northwick Park Hospital, London, UK between 12 March and 15 April 2020 with COVID-19 were retrospectively identified. The primary outcome was death. Associations were explored using Cox proportional hazards modelling. The study included 981 patients. The mortality rate was 36.0%. Age (adjusted hazard ratio (aHR) 1.53), respiratory disease (aHR 1.37), immunosuppression (aHR 2.23), respiratory rate (aHR 1.28), hypoxia (aHR 1.36), Glasgow Coma Scale <15 (aHR 1.92), urea (aHR 2.67), alkaline phosphatase (aHR 2.53), C-reactive protein (aHR 1.15), lactate (aHR 2.67), platelet count (aHR 0.77) and infiltrates on chest radiograph (aHR 1.89) were all associated with mortality. These important data will aid clinical risk stratification and provide direction for further research.